Impact BioMedical Inc’s recently made public that its Director Chan Heng Fai Ambrose unloaded Company’s shares for reported $0.53 million on Apr 02 ’25. In the deal valued at $0.60 per share,884,776 shares were sold. As a result of this transaction, Chan Heng Fai Ambrose now holds 351,555 shares worth roughly $0.34 million.
Then, Chan Heng Fai Ambrose sold 624,917 shares, generating $416,484 in total proceeds. Upon selling the shares at $0.67, the Director now owns 0 shares.
Before that, Chan Heng Fai Ambrose sold 180,000 shares. Impact BioMedical Inc shares valued at $172,800 were divested by the Director at a price of $0.96 per share. As a result of the transaction, Chan Heng Fai Ambrose now holds 0 shares, worth roughly $0.0.
Price Performance Review of IBO
On Friday, Impact BioMedical Inc [AMEX:IBO] saw its stock jump 107.48% to $0.96. Over the last five days, the stock has lost -36.66%. Impact BioMedical Inc shares have fallen nearly -33.61% since the year began.
Levels Of Support And Resistance For IBO Stock
The 24-hour chart illustrates a support level at 0.7578, which if violated will result in even more drops to 0.5529. On the upside, there is a resistance level at 1.1188. A further resistance level may holdings at 1.2749. The Relative Strength Index (RSI) on the 14-day chart is 45.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.1006, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.13%. Stochastics %K at 3.38% indicates the stock is a buying.
How much short interest is there in Impact BioMedical Inc?
A steep rise in short interest was recorded in Impact BioMedical Inc stocks on 2025-03-14, dropping by 3104.0 shares to a total of 9001.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 12105.0 shares. There was a decline of -34.49%, which implies that there is a negative sentiment for the stock.
